Connection

Yosuke Hirotsu to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Yosuke Hirotsu has written about Antibodies, Monoclonal.
Yosuke Hirotsu
Connection Strength
0.045
Antibodies, Monoclonal
  1. Very early response of circulating tumour-derived DNA in plasma predicts efficacy of nivolumab treatment in patients with non-small cell lung cancer. Eur J Cancer. 2017 11; 86:349-357.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.